"Overall, this study demonstrates the feasibility of applying QPOP as a functional combinatorial precision medicine platform to predict therapeutic sensitivities in AML and provides the basis for ...

The FDA approved treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell ...

Data elements obtained from the clinical databases for the three recent multinational openlabel clinical trials included patient age, sex, race, AML classification, the duration of first remission ...

The US National Institutes of Health (NIH) has launched a precision medicine trial that aims to match patients with myeloid leukaemia (AML) or myelodysplastic syndromes (MDS) to treatments based ...

I recently was invited to give a presentation about genomic alterations in AML at the 2024 ASTCT Clinical Education Conference for advanced practice providers, nurses and fellows.I was pleased to have ...

Tuspetinib selected for a prestigious national clinical research program for ability to target broad spectrum of AML and MDS populations ... The myeloMATCH precision medicine trials (NCT05564390 ...